Ana G. C.
- Country
- Spain
- Department
- Urology
Research Overview
Data & Insights
Has run more than one trial at 7 of 61 partner sites.
Specializations
Urological Oncology
The investigator specializes in treating non-muscle invasive bladder cancer (NMIBC), with particular focus on high-risk cases. Their expertise extends to innovative therapeutic approaches combining immunotherapy with established treatments.
- Bladder Cancer Management
- High-risk NMIBC Treatment
- Post-TURBT Care
Their work encompasses comprehensive treatment strategies following transurethral resection of bladder tumors (TURBT).
Immunotherapy Applications
The investigator focuses on integrating immunotherapeutic approaches in urological cancer treatment, particularly exploring the combination of novel immunologic agents with traditional therapies.
- Combined Immunotherapy Protocols
- BCG Treatment Enhancement
- Novel Therapeutic Combinations
Their expertise includes optimizing treatment outcomes through innovative immunological interventions in bladder cancer care.
Treatment Innovation
The investigator develops advanced therapeutic strategies for high-risk bladder cancer patients, focusing on improving survival outcomes through combined treatment modalities.
- Treatment Protocol Development
- Survival Outcome Enhancement
- Risk-adapted Therapeutic Approaches
Their work involves evaluating novel treatment combinations for patients who have not previously received conventional therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.